![Michael Secora](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Secora
Director of Finance/CFO at
Entos, Inc.
Profile
Currently, Michael Secora holds the position of Chief Financial Officer of Recursion Pharmaceuticals, Inc. and Portfolio Management at Laurion Capital Management LP. Dr. Secora received a graduate degree from Princeton University and an undergraduate degree from Massachusetts Institute of Technology.
Michael Secora active positions
| Companies | Position | Start |
|---|---|---|
Entos, Inc.
 Entos, Inc. Packaged SoftwareTechnology Services Develops AI driven platform for drug discovery | Director of Finance/CFO | 31/12/2024 |
Former positions of Michael Secora
| Companies | Position | End |
|---|---|---|
| RECURSION PHARMACEUTICALS, INC. | Director of Finance/CFO | 19/11/2024 |
Laurion Capital Management LP
 Laurion Capital Management LP Investment ManagersFinance LCM seeks to generate attractive returns on capital with controlled exposure to market direction. Their fund aims to profit from a global multi-disciplinary approach that uses a variety of trading strategies, including, among others, volatility trading strategies, model-based strategies, relative value strategies, event-driven strategies, and discretionary and macro-style trading strategies. It invests in a broad array of securities and derivatives under a range of different market scenarios, making use of these and other strategies. | Portfolio Manager-Equities | 31/12/2019 |
Training of Michael Secora
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
37
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Recursion Pharmaceuticals, Inc.
 Recursion Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that combines biology, chemistry, automation, data science and engineering to industrialize drug discovery | Health Technology |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Laurion Capital Management LP
Laurion Capital Management LP Investment ManagersFinance LCM seeks to generate attractive returns on capital with controlled exposure to market direction. Their fund aims to profit from a global multi-disciplinary approach that uses a variety of trading strategies, including, among others, volatility trading strategies, model-based strategies, relative value strategies, event-driven strategies, and discretionary and macro-style trading strategies. It invests in a broad array of securities and derivatives under a range of different market scenarios, making use of these and other strategies. | Finance |
Entos, Inc.
Entos, Inc. Packaged SoftwareTechnology Services Develops AI driven platform for drug discovery | Technology Services |
- Stock Market
- Insiders
- Michael Secora
